Endothelial progenitor cells: quod erat demonstrandum?
1Stem Cell Research Unit, Department of Hematology and Stem Cell Transplantation, University Clinic of Internal Medicine, Medical University, Auenbrugger Pl. 38, A-8036 Graz, Austria. dirk.strunk@klinikum-graz.at
Current Pharmaceutical Design
|September 17, 2011
Summary
Research on endothelial progenitor cells (EPCs) is advancing, but their precise function and phenotype remain unclear. Current models in animal studies offer tools to test agents for vascular regeneration and homeostasis.
Area of Science:
- Vascular Biology
- Regenerative Medicine
- Cell Biology
Background:
- Endothelial progenitor cells (EPCs) are crucial for maintaining blood vessel integrity and regeneration.
- Research over the past 15 years has aimed to understand EPC biology and function.
- Despite progress, the exact phenotype and function of EPCs are still not fully elucidated.
Purpose of the Study:
- To critically review the terminology, origin, and applicability of EPCs.
- To highlight the current understanding and limitations in EPC research.
- To discuss the utility of in vivo models for studying EPCs.
Main Methods:
- Literature review of recent research on endothelial progenitor cells.
- Analysis of current knowledge regarding EPC phenotype and function.
- Evaluation of animal models for studying human EPCs in vivo.
Main Results:
- EPCs are somatic progenitors involved in vessel maintenance and regeneration.
- Significant advancements have been made, yet precise EPC characterization remains a challenge.
- In vivo models are valuable for assessing vascular regenerative potential.
Conclusions:
- Further research is needed to definitively establish EPC phenotype and function.
- Understanding EPCs is key to developing novel regenerative therapies.
- Existing animal models provide a platform for testing therapeutic agents for vascular repair.
Related Concept Videos
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...